Valued with a market capitalization of $86.9 billion, Ecolab Inc. (ECL) is a Saint Paul, Minnesota-based company that provides water, hygiene, and infection prevention solutions and services.
Companies valued at $10 billion or more are typically classified as “large-cap stocks,” and Ecolab fits the label perfectly, as its market capitalization exceeds this threshold, underscoring its size, influence, and dominance within the specialty chemicals industry. The company’s strengths lie in its global scale, long-term customer relationships, regulatory expertise, and data-driven technologies that help customers improve operational efficiency, reduce water and energy use, and maintain high standards of safety and sustainability.
This provider of hygiene and infection prevention solutions is currently trading marginally below its 52-week high of $309.27, reached on February 24. ECL shares have risen 12.1% over the past three months, lagging the iShares US Basic Materials ETF’s (IYM) rise of 26.8% over the same time period.
Additionally, on a year-over-year basis, ECL shares are up 17.5%, compared to a 22.5% increase a year earlier. Longer term, ECL has gained 15.4% over the past 52 weeks, trailing AIM’s 37.6% rally over the same period.
Confirming its bullish trend, ECL has been trading above its 200-day and 50-day moving averages since early January.
On February 10, ECL shares soared 4% after the release of its better-than-expected fourth-quarter results. The company’s total revenue increased 4.8% year over year to $4.2 billion, beating consensus estimates by a slight margin. Additionally, its adjusted EPS of $2.08 improved 14.9% from the same period last year, beating analyst expectations of $2.06. The company is currently hitting all-time highs in early 2026, largely due to its defensive business model. Hospitals, hotels and food plants need your sanitation services regardless of whether the economy is booming or slowing.
ECL has also underperformed its rival, DuPont de Nemours, Inc. (DD), which has soared 47.8% over the past 52 weeks and 24.5% so far this year.
Despite Ecolab’s recent poor performance, analysts remain moderately optimistic about its prospects. The stock has a “Moderate Buy” consensus rating from the 28 analysts covering it, and the average price target of $323.52 suggests a 4.9% premium to its current price levels.
On the date of publication, Neharika Jain had no (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article are for informational purposes only. This article was originally published on Barchart.com